
Predictive testing in non-small cell lung carcinoma
Author(s) -
Pavel Dundr,
Radoslav Matěj,
Kristýěmejcová,
Michaela Bártů,
Ivana Stružinská
Publication year - 2021
Publication title -
klinická onkologie
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.204
H-Index - 13
eISSN - 1802-5307
pISSN - 0862-495X
DOI - 10.48095/ccko2021s29
Subject(s) - diagnostic test , predictive testing , clinical practice , lung cancer , medicine , process (computing) , computer science , oncology , medical physics , genetic testing , emergency medicine , family medicine , operating system
Predictive testing is a crucial part of the complete diagnostic process of non-small cell lung cancer (NSCLC) and a necessary requirement in order to determine proper course of treatment. However, the possibilities of testing and the spectrum of examined markers are quickly evolving as a result of the progress in diagnostic and therapeutic possibilities, and as such it is necessary to regularly update the current guidelines to achieve proper standards of care in routine practice.